(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -44.58%-1.88M | -21.81%-2.22M | 13.39%-2.69M | -2.60%-8.95M | -256.04%-2.71M | -3.09%-1.3M | 63.72%-1.83M | -86.66%-3.11M | -29.69%-8.72M | 53.19%-762K |
Net income from continuing operations | 151.55%22.29M | 11.47%21.61M | 216.04%14.9M | 175.78%48.66M | 2,002.30%15.69M | 7.72%8.86M | 156.41%19.39M | 75.86%4.71M | 192.85%17.64M | -109.52%-825K |
Operating gains losses | -87.32%-25.41M | -11.67%-25.26M | -149.17%-19.3M | -58.61%-65.03M | -516.60%-21.1M | -16.08%-13.56M | -86.24%-22.62M | 43.67%-7.74M | -157.11%-41M | 60.68%-3.42M |
Depreciation and amortization | -24.81%100K | 156.90%149K | 1,350.00%145K | 158.82%352K | 344.12%151K | 291.18%133K | 70.59%58K | -70.59%10K | -6.85%136K | -12.82%34K |
Asset impairment expenditure | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --10.47M | --0 |
Remuneration paid in stock | 20.56%991K | 4.05%1.05M | 26.61%966K | 0.89%3.28M | -26.82%682K | -26.15%822K | 42.94%1.01M | 53.52%763K | -23.64%3.25M | 36.66%932K |
Deferred tax | 20.04%1.21M | 62.41%1.3M | 216.03%1.08M | 1,403.23%5.58M | 2,111.61%3.43M | 83.94%1.01M | -37.17%798K | 121.41%343K | 123.68%371K | 104.71%155K |
Other non cashItems | -66.17%-447K | -142.92%-566K | -255.12%-451K | ---933K | ---304K | ---269K | ---233K | ---127K | ---- | ---- |
Change In working capital | -136.40%-621K | -121.83%-508K | 96.90%-33K | -308.07%-851K | -153.47%-1.26M | 241.20%1.71M | 90.68%-229K | -35,566.67%-1.06M | 12.36%409K | 140.24%2.36M |
-Change in receivables | -307.83%-584K | -122.22%-34K | -0.49%-206K | -239.92%-340K | -201.61%-569K | 232.55%281K | 455.81%153K | -230.65%-205K | 109.48%243K | 2,766.67%560K |
-Change in prepaid assets | -162.46%-401K | 4,305.56%757K | 8.93%-663K | 21.28%-555K | -274.81%-451K | 17.58%642K | -102.30%-18K | 68.21%-728K | -4,047.06%-705K | -35.34%258K |
-Change in payables and accrued expense | -53.51%364K | -238.19%-1.23M | 738.17%836K | -94.95%44K | -115.78%-244K | 371.69%783K | 88.61%-364K | -105.56%-131K | 228.68%871K | 155.12%1.55M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -44.58%-1.88M | -21.81%-2.22M | 13.39%-2.69M | -2.60%-8.95M | -256.04%-2.71M | -3.09%-1.3M | 63.72%-1.83M | -86.66%-3.11M | -29.69%-8.72M | 53.19%-762K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 132.83%17.26M | 8,323.40%23.19M | 130.92%8.65M | 61.67%-7.24M | 241.10%13.62M | 302.46%7.41M | 90.33%-282K | -949.06%-27.99M | 74.79%-18.9M | 44.12%-9.65M |
Net PPE purchase and sale | --0 | --0 | ---3.75M | --0 | --19K | 13.64%-19K | --0 | --0 | -600.00%-35K | --0 |
Net business purchase and sale | --0 | --0 | --0 | -120.34%-25.38M | --0 | 69.01%-53K | 60.67%-164K | -29,498.82%-25.16M | 84.47%-11.52M | 54.34%-8.38M |
Net investment purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -82.56%1.11M | --0 |
Interest received (cash flow from investment activities) | -71.34%715K | -52.53%1.49M | 1,567.11%2.48M | 114.34%7.64M | --1.85M | --2.5M | 4,814.06%3.15M | --149K | --3.56M | ---- |
Net other investing changes | 231.57%16.54M | 764.94%21.7M | 433.03%9.92M | 187.32%10.49M | 342.76%11.75M | 243.86%4.99M | -27.96%-3.26M | 19.36%-2.98M | -67.64%-12.02M | -162.99%-4.84M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 132.83%17.26M | 8,323.40%23.19M | 130.92%8.65M | 61.67%-7.24M | 241.10%13.62M | 302.46%7.41M | 90.33%-282K | -949.06%-27.99M | 74.79%-18.9M | 44.12%-9.65M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 797.09%924K | 1,680.61%1.55M | -100.07%-39K | 5,821.88%54.96M | -194.68%-925K | 467.86%103K | -1,500.00%-98K | 199,653.57%55.88M | -97.90%928K | -97.78%977K |
Net issuance payments of debt | -12.12%-37K | -22.58%-38K | -30.00%-39K | 1.83%-107K | 53.57%-13K | -17.86%-33K | -24.00%-31K | -7.14%-30K | -19.78%-109K | -7.69%-28K |
Net common stock issuance | --0 | --0 | --0 | --55.75M | ---1K | --136K | ---67K | --55.68M | --0 | --0 |
Proceeds from stock option exercised by employees | --961K | --1.59M | --0 | -70.40%307K | -91.84%82K | --0 | --0 | --225K | 5.28%1.04M | 26.73%1.01M |
Net other financing activities | ---- | ---- | ---- | ---993K | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 797.09%924K | 1,680.61%1.55M | -100.07%-39K | 5,821.88%54.96M | -194.68%-925K | 467.86%103K | -1,500.00%-98K | 199,653.57%55.88M | -97.90%928K | -97.78%977K |
Net cash flow | ||||||||||
Beginning cash position | 84.83%97.34M | 36.75%74.68M | 129.37%68.71M | -47.21%29.96M | 48.12%58.52M | 17.94%52.66M | 4.53%54.61M | -47.21%29.96M | -39.63%56.75M | 24.60%39.51M |
Current changes in cash | 162.31%16.3M | 1,121.13%22.52M | -76.09%5.92M | 245.28%38.77M | 205.76%9.98M | 225.51%6.21M | 72.23%-2.21M | 668.35%24.78M | 28.89%-26.69M | -137.57%-9.44M |
Effect of exchange rate changes | 59.33%-146K | -46.09%138K | 142.62%52K | 86.11%-15K | 279.49%210K | -82.23%-359K | -26.01%256K | 12.86%-122K | -140.75%-108K | -62.50%-117K |
End cash Position | 93.94%113.49M | 84.83%97.34M | 36.75%74.68M | 129.37%68.71M | 129.37%68.71M | 48.12%58.52M | 17.94%52.66M | 4.53%54.61M | -47.21%29.96M | -47.21%29.96M |
Free cash from | -42.50%-1.88M | -21.81%-2.22M | -107.41%-6.44M | -2.19%-8.95M | -253.54%-2.69M | -2.80%-1.32M | 63.81%-1.83M | -86.66%-3.11M | -30.12%-8.75M | 53.19%-762K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data